CompletedNot Applicable

BMT4me: Post-HSCT Medication Adherence mHealth App

United States50 participantsStarted 2022-11-29

Plain-language summary

This is a mixed methods, prospective longitudinal pilot RCT to evaluate the 1) acceptability of a newly developed mHealth app (BMT4me), 2) the feasibility of enrolling and retaining caregivers of children in the acute phase post-HSCT, and 3) the potential efficacy of an mHealth app on adherence to immunosuppressants in post-HSCT children discharged during the acute phase.

Who can participate

Age range0 Years – 21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children of caregivers must be a) 0 to 21 years of age; b) receiving immunosuppression for an allogeneic transplant or anti-infective for an autologous transplant; c) discharged prior to Day 100 or completion of immunosuppression taper, and d) residing with the primary caregiver that enrolls on the study. * Primary caregivers must be: d) English-speaking; and e) have an iOS or Android capable cellular device. Exclusion Criteria: * Adults unable to consent

What they're measuring

Momentary Event Monitoring System (MEMS) Caps

Timeframe: Baseline to day 100

Medication Adherence Measure (MAM)

Timeframe: Baseline to day 100

System Usability Scale

Timeframe: Exit (Day 100)

Posttransplant Perception Survey

Timeframe: Baseline (Week 0)

Barrier Assessment Tool

Timeframe: Baseline (Week 0)

Caregiver Satisfaction

Timeframe: Exit (Day 100)

Pediatric Quality of Life Inventory (PedsQL) version 4.0

Timeframe: Week 3, Week 6, and Week 9

Medy Remote Patient Management (RPM) medication box by Vaica

Timeframe: Baseline to day 100

Trial details

NCT IDNCT05515497

SponsorMicah Skeens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-21

View on ClinicalTrials.gov More Stem Cell Transplant trials